Purple Biotech Ltd (PPBT) Stock Price, Quote, News & History

PPBTNASDAQ
$3.09
0.144.75%
At close: Jun 3, 5:00 PM EST
$2.92
-0.03-1.02%
Pre-Market: 4:15 AM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-6.80M
Investing Cash Flow (TTM)
420.00K
Financing Cash Flow (TTM)
6.17M
Free Cash Flow (TTM)
-6.80M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-213.00K

Analyst Trends and Forecast

1
Mar
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$408.08K
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.28
Earnings Yield % (TTM)
109571.36%
Earnings Yield % (FWD)
-180.01%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$10.43

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$223.00K
Total Cash
$5.57M
Debt to Equity
0.02
Issuance of Debt (TTM)
-$223.00K
Repayment of Debt (TTM)
-$223.00K

Key Statistics

Open
-
Close
$3.09
Volume / Avg.
117.00 / 112.67K
Day Range
- - -
52 Wk Range
2.52 - 29.00
Market Cap
$2.72M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
0.8%
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and I...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Purple Biotech (PPBT) stock?

A

You can purchase shares of Purple Biotech (NASDAQ:PPBT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Purple Biotech (PPBT) competitors?

A

There are no as such competitors for Purple Biotech.

Q

What is the forecast, or price target, for Purple Biotech (PPBT) stock?

A

Purple Biotech has a consensus price target of $16.33.

Q

What is the current price for Purple Biotech (PPBT)?

A

The stock price for Purple Biotech (NASDAQ: PPBT) is $2.92 last updated June 4, 2026 at 5:28 PM EDT.

Q

Does Purple Biotech (PPBT) pay a dividend?

A

There are no upcoming dividends for Purple Biotech.

Q

When is Purple Biotech (NASDAQ:PPBT) reporting earnings?

A

Purple Biotech does not have any upcoming earnings scheduled.

Q

Is Purple Biotech (PPBT) going to split?

A

There is no upcoming split for Purple Biotech.

Q

What sector and industry does Purple Biotech (PPBT) operate in?

A

Purple Biotech is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.